Personal information

Other IDs

Scopus Author ID: 57188816455
Scopus Author ID: 57208583952

Activities

Collapse all

Works (50 of 80)

Items per page:
Page 1 of 2

Climate change and the role of dermatologists: a call to action

Clinical and Experimental Dermatology
2024-12-09 | Journal article
DOI: 10.1093/ced/llae526
Contributors: Luca Potestio; Fabrizio Martora; Alessia Villani; Matteo Megna
Source: check_circle
Crossref

Author reply to ‘Comment on ChatGPT and medical writing in dermatology: why should we keep writing?’

Clinical and Experimental Dermatology
2024-10-24 | Journal article
DOI: 10.1093/ced/llae177
Contributors: Luca Potestio; Matteo Megna; Sara Cacciapuoti; Fabrizio Martora; Alessia Villani
Source: check_circle
Crossref

CorrespondenceAuthor reply to ‘Comment on ChatGPT and medical writing in dermatology: why should we keep writing?’ by Duff et al.

Clinical and Experimental Dermatology
2024-10-24 | Journal article
DOI: 10.1093/ced/llae178
Contributors: Luca Potestio; Matteo Megna; Sara Cacciapuoti; Fabrizio Martora; Alessia Villani
Source: check_circle
Crossref

ChatGPT and medical writing in dermatology: why should we keep writing?

Clinical and Experimental Dermatology
2024-07-19 | Journal article
DOI: 10.1093/ced/llae105
Contributors: Luca Potestio; Matteo Megna; Sara Cacciapuoti; Fabrizio Martora; Alessia Villani
Source: check_circle
Crossref

Advancing dermatology: embracing the power of artificial intelligence. Comment on ‘Artificial intelligence-assisted publishing in five prominent dermatology journals: a quantitative study of recent publications’

Clinical and Experimental Dermatology
2024-06-25 | Journal article
DOI: 10.1093/ced/llad281
Contributors: Luca Potestio; Fabrizio Martora; Alessia Villani; Sara Cacciapuoti; Teresa Battista; Matteo Megna
Source: check_circle
Crossref

ChatGPT and dermatology: friends or foes?

Clinical and Experimental Dermatology
2024-06-25 | Journal article
DOI: 10.1093/ced/llad227
Contributors: Luca Potestio; Fabrizio Martora; Alessia Villani; Angelo Ruggiero; Massimiliano Scalvenzi; Matteo Megna
Source: check_circle
Crossref

Viral reactivation following COVID-19 vaccination: a review of the current literature

Clinical and Experimental Dermatology
2024-05-21 | Journal article
DOI: 10.1093/ced/llae061
Contributors: Fabrizio Martora; Matteo Megna; Teresa Battista; Massimiliano Scalvenzi; Alessia Villani; Sara Cacciapuoti; Luca Potestio
Source: check_circle
Crossref

Comment on ‘Development of chilblain lesions during the COVID-19 pandemic is strongly associated with cold weather: a retrospective analysis of patients from a single centre in the USA’

Clinical and Experimental Dermatology
2024-03-21 | Journal article
DOI: 10.1093/ced/llad445
Contributors: Luca Potestio; Fabrizio Martora; Matteo Megna; Alessia Villani; Sara Cacciapuoti
Source: check_circle
Crossref

Comment on: ‘Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination’ by Gambichler

Journal of the European Academy of Dermatology and Venereology
2023-10 | Journal article
DOI: 10.1111/jdv.19264
Contributors: Luca Potestio; Fabrizio Martora; Alessia Villani; Matteo Megna; Angelo Ruggiero
Source: check_circle
Crossref

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area

Dermatology and Therapy
2023-09 | Journal article
DOI: 10.1007/s13555-023-00985-1
Contributors: Alessia Villani; Gabriella Fabbrocini; Giuseppe Micali; Luigi Fornaro; Luca Potestio; Massimiliano Scalvenzi
Source: check_circle
Crossref

Letter to the editor regarding article “Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID‐19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256”

Journal of Cosmetic Dermatology
2023-03 | Journal article
DOI: 10.1111/jocd.15504
Contributors: Luca Potestio; Alessia Villani; Flavia Raia; Gabriella Fabbrocini; Fabrizio Martora
Source: check_circle
Crossref

Cutaneous adverse reaction following COVID‐19 vaccination: Report from a southern Italian referral centre. Comment on “cutaneous adverse reactions following the Pfizer/BioNTech COVID‐19 vaccine” by Luo et al.

Australasian Journal of Dermatology
2023-02 | Journal article
DOI: 10.1111/ajd.13984
Contributors: Fabrizio Martora; Alessia Villani; Claudio Marasca; Gabriella Fabbrocini; Angelo Ruggiero
Source: check_circle
Crossref

Reply to ‘Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.

Journal of the European Academy of Dermatology and Venereology
2023-02 | Journal article
DOI: 10.1111/jdv.18512
Contributors: Angelo Ruggiero; Fabrizio Martora; Fabrizio Fornaro; Massimiliano Scalvenzi; Gabriella Fabbrocini; Alessia Villani
Source: check_circle
Crossref

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?

Journal of Cosmetic Dermatology
2023-02 | Journal article
DOI: 10.1111/jocd.15292
Contributors: Angelo Ruggiero; Claudio Marasca; Gabriella Fabbrocini; Alessia Villani; Fabrizio Martora
Source: check_circle
Crossref

COVID‐19 and cutaneous manifestations: A review of the published literature

Journal of Cosmetic Dermatology
2023-01 | Journal article
DOI: 10.1111/jocd.15477
Contributors: Fabrizio Martora; Alessia Villani; Gabriella Fabbrocini; Teresa Battista
Source: check_circle
Crossref

COVID‐19 vaccination and inflammatory skin diseases

Journal of Cosmetic Dermatology
2023-01 | Journal article
DOI: 10.1111/jocd.15414
Contributors: Fabrizio Martora; Alessia Villani; Teresa Battista; Gabriella Fabbrocini; Luca Potestio
Source: check_circle
Crossref

Effects of COVID‐19 pandemic on malignant melanoma diagnosis

Journal of the European Academy of Dermatology and Venereology
2023-01 | Journal article
DOI: 10.1111/jdv.18545
Contributors: Alessia Villani; Massimiliano Scalvenzi; Gabriella Fabbrocini; Luigi Fornaro; Gianluca Guerrasio; Luca Potestio
Source: check_circle
Crossref

Letter to the editor regarding article “Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic‐Massari L. New‐onset lichen planus and lichen planus flare in elderly women after COVID‐19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185”

Journal of Cosmetic Dermatology
2023-01 | Journal article
DOI: 10.1111/jocd.15491
Contributors: Luca Potestio; Alessia Villani; Gabriella Fabbrocini; Fabrizio Martora
Source: check_circle
Crossref

Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’

Journal of the European Academy of Dermatology and Venereology
2023-01 | Journal article
DOI: 10.1111/jdv.18531
Contributors: Fabrizio Martora; Alessia Villani; Claudio Marasca; Gabriella Fabbrocini; Luca Potestio
Source: check_circle
Crossref

Cutaneous reactions following booster dose of COVID‐19 mRNA vaccination: What we should know?

Journal of Cosmetic Dermatology
2022-11 | Journal article
DOI: 10.1111/jocd.15331
Contributors: Luca Potestio; Alessia Villani; Gabriella Fabbrocini; Fabrizio Martora
Source: check_circle
Crossref

Letter to the editor regarding article “Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in‐person visits at an academic center during the COVID‐19 pandemic. J Cosmet Dermatol. 2022;21(1):36–38.”

Journal of Cosmetic Dermatology
2022-11 | Journal article
DOI: 10.1111/jocd.15018
Contributors: Luca Potestio; Gabriella Fabbrocini; Alessia Villani
Source: check_circle
Crossref

Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic

Dermatologic Therapy
2022-11 | Journal article
DOI: 10.1111/dth.15786
Contributors: Alessia Villani; Luca Potestio; Gabriella Fabbrocini; Francesca di Vico; Claudia Costa; Massimiliano Scalvenzi
Source: check_circle
Crossref

Reply to ‘Cutaneous adverse effects of the available COVID‐19 vaccines in India: A questionnaire‐based study’ by Bawane J et al.

Journal of the European Academy of Dermatology and Venereology
2022-11 | Journal article
DOI: 10.1111/jdv.18341
Contributors: L. Potestio; L. Genco; A. Villani; C. Marasca; G. Fabbrocini; L. Fornaro; A. Ruggiero; F. Martora
Source: check_circle
Crossref

Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on ‘A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department’

Clinical and Experimental Dermatology
2022-11-01 | Journal article
DOI: 10.1111/ced.15326
Contributors: Fabrizio Martora; Angelo Ruggiero; Gabriella Fabbrocini; Alessia Villani
Source: check_circle
Crossref

The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre

Clinical and Experimental Dermatology
2022-11-01 | Journal article
DOI: 10.1111/ced.15307
Contributors: Angelo Ruggiero; Fabrizio Martora; Luigi Fornaro; Gianluca Guerrasio; Francesca di Vico; Gabriella Fabbrocini; Massimiliano Scalvenzi; Alessia Villani
Source: check_circle
Crossref

Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment

Clinical and Experimental Dermatology
2022-10-01 | Journal article
DOI: 10.1111/ced.15299
Contributors: Angelo Ruggiero; Claudio Marasca; Alessia Villani; Gabriella Fabbrocini; Fabrizio Martora
Source: check_circle
Crossref

Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation

Dermatologic Therapy
2022-09 | Journal article
DOI: 10.1111/dth.15679
Contributors: Matteo Megna; Alessia Villani; Luca Potestio; Elisa Camela; Gabriella Fabbrocini; Sonia Sofia Ocampo‐Garza
Source: check_circle
Crossref

Giant basal cell carcinoma of the vulva successfully treated with Sonidegib

Dermatologic Therapy
2022-09 | Journal article
DOI: 10.1111/dth.15723
Contributors: Elisa Camela; Alessia Villani; Massimiliano Scalvenzi; Claudia Costa
Source: check_circle
Crossref

Maskne prevalence and risk factors during the COVID‐19 pandemic

Journal of the European Academy of Dermatology and Venereology
2022-09 | Journal article
DOI: 10.1111/jdv.18248
Contributors: A. Villani; G. Fabbrocini; M.C. Annunziata; L. Potestio
Source: check_circle
Crossref

Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy

Dermatologic Therapy
2022-07 | Journal article
DOI: 10.1111/dth.15539
Contributors: Alessia Villani; Gabriella Fabbrocini; Tiziana Peduto; Massimiliano Scalvenzi
Source: check_circle
Crossref

Sonidegib‐induced muscle spasms in the treatment of basal cell carcinoma: Strategies to adopt

Dermatologic Therapy
2022-07 | Journal article
DOI: 10.1111/dth.15531
Contributors: Alessia Villani; Gabriella Fabbrocini; Massimiliano Scalvenzi
Source: check_circle
Crossref

Teledermatology: A useful tool also after COVID‐19 era?

Journal of Cosmetic Dermatology
2022-06 | Journal article
DOI: 10.1111/jocd.14938
Contributors: Matteo Megna; Elisa Camela; Alessia Villani; Andrea Tajani; Gabriella Fabbrocini; Luca Potestio
Source: check_circle
Crossref

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas

The Oncologist
2022-06-08 | Journal article
DOI: 10.1093/oncolo/oyac063
Contributors: Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Luca Potestio; Massimiliano Scalvenzi
Source: check_circle
Crossref

New‐onset lichen planus arising after COVID‐19 vaccination

Dermatologic Therapy
2022-05 | Journal article
DOI: 10.1111/dth.15374
Contributors: Orlando Zagaria; Alessia Villani; Angelo Ruggiero; Luca Potestio; Gabriella Fabbrocini; Lucia Gallo
Source: check_circle
Crossref

Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview

Journal of the European Academy of Dermatology and Venereology
2022-04 | Journal article
DOI: 10.1111/jdv.17831
Contributors: A. Villani; M. Scalvenzi; T. Peduto; E. Cinelli; G. Fabbrocini; A. Di Stefani
Source: check_circle
Crossref

Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation

Dermatologic Therapy
2022-04 | Journal article
DOI: 10.1111/dth.15332
Contributors: Sonia Sofia Ocampo‐Garza; Alessia Villani; Eleonora Cinelli; Elisa Camela; Gabriella Fabbrocini; Matteo Megna
Source: check_circle
Crossref

Long‐term results of teledermatology for acne patients during COVID‐19 pandemic

Journal of Cosmetic Dermatology
2022-04 | Journal article
DOI: 10.1111/jocd.14805
Contributors: Alessia Villani; Maria Carmela Annunziata; Matteo Megna; Massimiliano Scalvenzi; Gabriella Fabbrocini
Source: check_circle
Crossref

Sonidegib treatment in patients with locally advanced basal cell carcinoma

Dermatologic Therapy
2022-04 | Journal article
DOI: 10.1111/dth.15348
Contributors: Alessia Villani; Gabriella Fabbrocini; Massimiliano Scalvenzi
Source: check_circle
Crossref

Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience

Dermatologic Therapy
2022-01 | Journal article
DOI: 10.1111/dth.15195
Contributors: Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Massimiliano Scalvenzi
Source: check_circle
Crossref

Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head–neck region: A retrospective study

Dermatologic Therapy
2021-09 | Journal article
DOI: 10.1111/dth.15036
Contributors: Alessia Villani; Claudia Costa; Gabriella Fabbrocini; Massimiliano Scalvenzi
Source: check_circle
Crossref

Nail changes as manifestation of systemic disease in COVID‐19 infection

Journal of the European Academy of Dermatology and Venereology
2021-08 | Journal article
DOI: 10.1111/jdv.17273
Contributors: S.S. Ocampo‐Garza; J. Ocampo‐Candiani; E. Camela; M. Vastarella; G. Fabbrocini; M. Scalvenzi; A. Villani
Source: check_circle
Crossref

Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose

Journal of the European Academy of Dermatology and Venereology
2021-07 | Journal article
DOI: 10.1111/jdv.17216
Contributors: A. Villani; G. Fabbrocini; J. Ocampo‐Candiani; A. Ruggiero; S.S. Ocampo‐Garza
Source: check_circle
Crossref

Looking into a Better Future: Novel Therapies for Metastatic Melanoma

Dermatology and Therapy
2021-06-17 | Journal article
DOI: 10.1007/s13555-021-00525-9
Contributors: Alessia Villani; Massimiliano Scalvenzi; Gabriella Fabbrocini; Jorge Ocampo-Candiani; Sonia Sofía Ocampo-Garza
Source: check_circle
Crossref

Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case

Dermatology and Therapy
2021-06-15 | Journal article
DOI: 10.1007/s13555-021-00533-9
Contributors: Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Massimiliano Scalvenzi
Source: check_circle
Crossref

Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single‐centre retrospective study

Australasian Journal of Dermatology
2021-05 | Journal article
DOI: 10.1111/ajd.13488
Contributors: Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Milena Cappello; Massimiliano Scalvenzi
Source: check_circle
Crossref

Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review

Dermatologic Therapy
2021-03-17 | Journal article
DOI: 10.1111/dth.14857
Contributors: Elisa Camela; Sonia Sofía Ocampo‐Garza; Eleonora Cinelli; Alessia Villani; Gabriella Fabbrocini; Matteo Megna
Source: check_circle
Crossref

Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience

Dermatologic Therapy
2021-03-13 | Journal article
DOI: 10.1111/dth.14728
Contributors: Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Massimiliano Scalvenzi
Source: check_circle
Crossref

SMS support group in the management of acne: A useful tool to increase adherence to treatment

Dermatologic Therapy
2021-01 | Journal article
DOI: 10.1111/dth.14663
Contributors: Angelo Ruggiero; Claudio Marasca; Sonia Sofia Ocampo‐Garza; Gabriella Fabbrocini; Alessia Villani
Source: check_circle
Crossref

Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families

Clinical and Experimental Dermatology
2020-12-26 | Journal article
DOI: 10.1111/ced.14287
Contributors: A. Villani; M. Cappello; C. Costa; G. Fabbrocini; M. Scalvenzi
Source: check_circle
Crossref

Complete remission of an advanced basal cell carcinoma after only 3‐month treatment with sonidegib: Report of a case and drug management during COVID ‐19 pandemic

Dermatologic Therapy
2020-11 | Journal article
DOI: 10.1111/dth.14200
Contributors: Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Massimiliano Scalvenzi
Source: check_circle
Crossref
Items per page:
Page 1 of 2
How many people are using ORCID?